DE69127572D1 - Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen - Google Patents
Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-StörungenInfo
- Publication number
- DE69127572D1 DE69127572D1 DE69127572T DE69127572T DE69127572D1 DE 69127572 D1 DE69127572 D1 DE 69127572D1 DE 69127572 T DE69127572 T DE 69127572T DE 69127572 T DE69127572 T DE 69127572T DE 69127572 D1 DE69127572 D1 DE 69127572D1
- Authority
- DE
- Germany
- Prior art keywords
- amino acids
- nervous system
- central nervous
- excitatory amino
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50928490A | 1990-04-13 | 1990-04-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69127572D1 true DE69127572D1 (de) | 1997-10-16 |
DE69127572T2 DE69127572T2 (de) | 1998-01-22 |
Family
ID=24026006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69127572T Expired - Fee Related DE69127572T2 (de) | 1990-04-13 | 1991-03-27 | Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0451626B1 (de) |
JP (1) | JP3015129B2 (de) |
AT (1) | ATE157873T1 (de) |
CA (1) | CA2040242A1 (de) |
DE (1) | DE69127572T2 (de) |
DK (1) | DK0451626T3 (de) |
ES (1) | ES2108017T3 (de) |
FI (1) | FI911784A (de) |
GR (1) | GR3025186T3 (de) |
IE (1) | IE910939A1 (de) |
NO (1) | NO911449L (de) |
PT (1) | PT97365B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5317018A (en) * | 1992-06-09 | 1994-05-31 | Armin Walser | Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy |
EP1156043B1 (de) * | 1992-07-24 | 2003-11-12 | The Regents Of The University Of California | Arzneimittel die den durch AMPA Rezeptoren vermittelten synaptischen Response erhöhen |
US5852008A (en) * | 1995-01-24 | 1998-12-22 | The Regents Of The University Of California | Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors |
GB2316616A (en) * | 1996-09-02 | 1998-03-04 | Lilly Industries Ltd | Modulation of GluR5 receptors in the hippocampus to treat psychiatric disorders |
KR102362725B1 (ko) * | 2018-10-22 | 2022-02-15 | (주)엘엑스하우시스 | 창호 시공용 낙하방지망 조립체 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MC1528A1 (fr) * | 1982-07-21 | 1984-04-13 | Hoffmann La Roche | Imidazobenzodiazepines |
CA1327008C (en) * | 1988-01-15 | 1994-02-15 | Walter Merz | Anti-psychotic imidazobenzodiazepine |
-
1991
- 1991-03-21 IE IE093991A patent/IE910939A1/en unknown
- 1991-03-27 DE DE69127572T patent/DE69127572T2/de not_active Expired - Fee Related
- 1991-03-27 AT AT91104888T patent/ATE157873T1/de not_active IP Right Cessation
- 1991-03-27 DK DK91104888.2T patent/DK0451626T3/da active
- 1991-03-27 ES ES91104888T patent/ES2108017T3/es not_active Expired - Lifetime
- 1991-03-27 EP EP91104888A patent/EP0451626B1/de not_active Expired - Lifetime
- 1991-04-11 CA CA002040242A patent/CA2040242A1/en not_active Abandoned
- 1991-04-12 PT PT97365A patent/PT97365B/pt not_active IP Right Cessation
- 1991-04-12 JP JP3079900A patent/JP3015129B2/ja not_active Expired - Fee Related
- 1991-04-12 FI FI911784A patent/FI911784A/fi not_active Application Discontinuation
- 1991-04-12 NO NO91911449A patent/NO911449L/no unknown
-
1997
- 1997-10-29 GR GR970402821T patent/GR3025186T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0451626A2 (de) | 1991-10-16 |
JPH04224516A (ja) | 1992-08-13 |
FI911784A0 (fi) | 1991-04-12 |
FI911784A (fi) | 1991-10-14 |
PT97365B (pt) | 1998-08-31 |
GR3025186T3 (en) | 1998-02-27 |
PT97365A (pt) | 1992-01-31 |
NO911449L (no) | 1991-10-14 |
IE910939A1 (en) | 1991-10-23 |
DK0451626T3 (da) | 1998-04-20 |
EP0451626B1 (de) | 1997-09-10 |
NO911449D0 (no) | 1991-04-12 |
EP0451626A3 (en) | 1992-10-07 |
ES2108017T3 (es) | 1997-12-16 |
CA2040242A1 (en) | 1991-10-14 |
ATE157873T1 (de) | 1997-09-15 |
DE69127572T2 (de) | 1998-01-22 |
JP3015129B2 (ja) | 2000-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI941378A (fi) | Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus | |
ATE83659T1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
EA200000592A1 (ru) | Азаполициклические соединения, конденсированные с арилом | |
DE69201948T2 (de) | Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b. | |
DE69738245D1 (de) | 1,2-Diphenylpyrrol-Derivate, ihre Herstellung und therapeutische Verwendung | |
DE3888340D1 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
DE68908145T2 (de) | Verwendung von L-Carnitinderivaten zur Herstellung eines Arzneimittels zur therapeutischen Behandlung von peripheren Neuropathien. | |
FI935800A (fi) | Masennuksenvastaisia ja Parkinsonin taudin vastaisia yhdisteitä | |
DE69127572D1 (de) | Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen | |
DE69421457T2 (de) | Verwendung von N-(Pyridinyl)-1H-Indol-1-Aminen zur Herstellung eines Medikamentes zur Behandlung von zwangsneurotischen Erkrankungen | |
ATE236634T1 (de) | Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen | |
ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
ATE100102T1 (de) | Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
IT1241927B (it) | 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono | |
DE69327077T2 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
ATE108444T1 (de) | 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |